Poly Medicure Announces Q4 FY26 Results, Recommends Rs. 3.5 Dividend Per Share

Poly Medicure Announces Q4 FY26 Results, Recommends Rs. 3.5 Dividend Per Share

Poly Medicure Announces Q4 FY26 Results, Recommends Rs. 3.5 Dividend Per Share​

Poly Medicure Limited announced the outcomes of its Board of Directors meeting held on May 25, 2026. The board approved the audited financial results for the fourth quarter and financial year ended March 31, 2026, and recommended a dividend of Rs. 3.5 per equity share for the Financial Year 2025-26, pending shareholder approval.

The company also confirmed the re-appointment of auditors for the financial year 2026-27.

Financial Highlights for Q4 FY26​

The consolidated financial statements show the company achieved a Total Comprehensive Income of 36,721.58 lacs for the year ended March 31, 2026.

The key performance figures for the year and quarter ended March 31, 2026, are summarized below:

Statement of Standalone and Consolidated Financial Results (in lacs)

ParticularsQuarter Ended 31.03.2026Quarter Ended 31.03.2025Year Ended 31.03.2026Year Ended 31.03.2025
Total Income from Operations45,813.6849,180.3699,534.14-
Net Profit/(Loss) for the period (before Tax, Exceptional items)10,680.6211,649.6343,427.5145,251.51
Total Comprehensive Income8,125.008,662.0636,721.5833,720.25
Earnings per Basic Share7.958.4031.7934.13

Dividend and Audit Appointments​

The Board of Directors recommended a dividend of Rs. 3.5 (Three Rupees and Fifty Paisa) per Equity Share, which is based on the 70% paid-up equity share capital of Rs. 5 each, for the Financial Year 2025-26. This dividend recommendation is subject to the approval of the shareholders.

Regarding the appointment of auditors, the board approved the following re-appointments for the Financial Year 2026-27:

RoleFirm Name
Internal AuditorM/s PricewaterhouseCoopers Services LLP
Internal AuditorM/s Oswal Sunil & Co. Chartered Accountants

Analysis of Financial Position (As at March 31, 2026)​

The Balance Sheet data reveals the total asset and liability structure of the company.

Summary of Total Assets and Liabilities (in lacs)

ParticularsStandalone (31.03.2026)Consolidated (31.03.2026)
Total Assets354,994.89391,856.72
Total Equity (excluding Revaluation Reserves)300,203.27305,549.30
Total Liabilities7,796.3519,380.16
Total Assets354,994.89391,856.72

Operational Activities and Acquisitions​

The company's consolidated results incorporate significant details regarding its group structure and recent acquisitions.

The Group successfully acquired 90% economic rights in Pendracare Group (comprising Pendracare Holdings BV and Wellinq Medical BV) through RISOR Holding BV, which is wholly owned by Poly Medicure BV, Netherlands.

Another major acquisition detailed in the consolidated financial statements includes the group's hold of 100% economic rights in Medistream SA, Switzerland, through its subsidiary, Poly Medicure BV.

Additionally, the consolidated financial statements include the results related to the resolution plan for Himalayan Mineral Water Private Limited, with the company depositing a sum of Rs. 3,316.00 lacs towards the resolution professional.

POLYMED Stock Price Movement​

Poly Medicure Limited shares slipped today, settling at ₹1569.0 after shedding 1.83% in post-market trading. The stock saw a total volume of 121,753 shares executed during the session.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top